KRISTIN GUIDRY: Open Payments
NPI 1588194641 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,924 in 94 payments from 22 companies in 2025. Trend: 2023 $1,832 · 2024 $2,254 · 2025 $1,924
Food & beverage: $1,924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $533 |
| PFIZER INC. | 14 | $185 |
| Medtronic, Inc. | 1 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| Axsome Therapeutics, Inc. | 5 | $140 |
| GlaxoSmithKline, LLC. | 6 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| Novo Nordisk Inc | 5 | $88 |
| Astellas Pharma US Inc | 4 | $84 |
| Lilly USA, LLC | 4 | $67 |
Products named: UBRELVY, VRAYLAR, COREVALVE EVOLUT R, Auvelity, AIRSUPRA, Kerendia, Veozah, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
